We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $783M
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P
Everpure Inc
P
+$3.43M

Top Sells

Rank Stock Value
1
CPRX
Catalyst Pharmaceutical
CPRX
+$11.2M
2
BAP icon
Credicorp
BAP
+$9.17M
3
NXT icon
Nextpower Inc. Common Stock
NXT
+$6.93M
4
XP icon
XP
XP
+$6.54M
5
STRL icon
Sterling Infrastructure
STRL
+$5.21M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMT icon
351
Lockheed Martin
LMT
$124B
$129K 0.02%
253
– –
GERN icon
352
Geron
GERN
$848M
$128K 0.02%
+100,355
New +$141K
YOU icon
353
Clear Secure
YOU
$4.13B
$128K 0.02%
+2,295
New +$125K
ATRC icon
354
AtriCure
ATRC
$3.01B
$126K 0.02%
4,496
– –
MORN icon
355
Morningstar
MORN
$7.61B
$122K 0.02%
780
– –
BWMN icon
356
Bowman Consulting
BWMN
$736M
$121K 0.02%
+4,155
New +$131K
MGY icon
357
Magnolia Oil & Gas
MGY
$6.91B
$121K 0.02%
+4,725
New +$135K
PAYC icon
358
Paycom
PAYC
$10.2B
$118K 0.02%
+938
New +$122K
HRMY icon
359
Harmony Biosciences
HRMY
$2.49B
$117K 0.01%
3,203
– –
FDS icon
360
Factset
FDS
$9.92B
$115K 0.01%
499
– –
CHWY icon
361
Chewy
CHWY
$8.4B
$109K 0.01%
+5,535
New +$126K
REPX icon
362
Riley Exploration Permian
REPX
$959M
$108K 0.01%
+3,282
New +$117K
BOX icon
363
Box
BOX
$4.76B
$102K 0.01%
3,844
– –
URBN icon
364
Urban Outfitters
URBN
$6.5B
$97.6K 0.01%
1,378
– –
MCRI icon
365
Monarch Casino & Resort
MCRI
$2.2B
$97.1K 0.01%
738
+70
+10% +$8.16K
CVSA
366
Covista Inc
CVSA
$4.3B
$95.1K 0.01%
763
– –
CRM icon
367
Salesforce
CRM
$200B
$94K 0.01%
600
– –
DY icon
368
Dycom Industries
DY
$8.61B
$89.5K 0.01%
+177
New +$77.4K
OPHC icon
369
OptimumBank Holdings
OPHC
$116M
$89.1K 0.01%
15,253
+3,089
+25% +$17K
MMSI icon
370
Merit Medical Systems
MMSI
$5.11B
$87.2K 0.01%
1,257
– –
VMD icon
371
Viemed Healthcare
VMD
$341M
$85.7K 0.01%
7,516
– –
BWXT icon
372
BWX Technologies
BWXT
$13.4B
$79.8K 0.01%
+410
New +$85.4K
LTRX icon
373
Lantronix
LTRX
$272M
$76.4K 0.01%
12,990
– –
TTEK icon
374
Tetra Tech
TTEK
$9.25B
$72.2K 0.01%
2,500
– –
BMBL icon
375
Bumble
BMBL
$391M
$70.4K 0.01%
22,000
– –
13 14
15
16 17

Similar funds

CC
Converium Capital Montreal $783M AUM
CCG
Chatham Capital Group Savannah, Georgia $783M AUM 31.99% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
LF
Lee Financial Dallas, Texas $783M AUM 23.98% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $783M AUM 19.25% 1-Year Est. Return
SFWA
Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
CWP
CFM Wealth Partners Austin, Texas $783M AUM 47.07% 1-Year Est. Return

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.